This inventor holds 9 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignees: Two Blades Foundation, Other. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Norwich, GB (2013 - 2016)
- Cambridge, GB (2015 - 2023)
Company Filing History:
Years Active: 2013-2023
Title: Sebastian Schornack: Innovator in DNA-Binding Technologies
Introduction
Sebastian Schornack is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the area of DNA-binding technologies. With a total of 9 patents to his name, Schornack's work has the potential to impact various applications in genetic research and therapy.
Latest Patents
One of Schornack's latest patents is focused on modular DNA-binding domains and methods of use. This invention refers to methods for selectively recognizing a base pair in a DNA sequence by a polypeptide. It also includes modified polypeptides that specifically recognize one or more base pairs in a DNA sequence. Additionally, the patent discusses DNA that is modified to be specifically recognized by a polypeptide, along with the uses of the polypeptide and DNA in specific DNA targeting. Furthermore, it outlines methods of modulating the expression of target genes in a cell.
Career Highlights
Throughout his career, Schornack has worked with notable organizations, including the Two Blades Foundation. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements in genetic engineering and molecular biology.
Collaborations
Some of Schornack's notable coworkers include Ulla Bonas and Jens Boch. Their collaborative efforts have likely enhanced the research and development of the technologies he has pioneered.
Conclusion
Sebastian Schornack's contributions to the field of DNA-binding technologies exemplify the impact of innovative thinking in biotechnology. His patents and collaborations continue to pave the way for advancements in genetic research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile